In a recent development involving a significant intellectual property case, Sun Pharmaceutical Industries has formally requested the recusal of a New Jersey federal judge. The case focuses on allegations that Sun Pharmaceutical’s alopecia treatment infringes upon a patent held by Incyte Corporation. The call for recusal arises from the fact that Incyte’s legal counsel employed the judge’s former law clerk, subsequently assigning him to this particular case. Sun Pharmaceutical argues that this situation creates “an indelible appearance of impropriety,” which may affect the integrity and impartiality of judicial proceedings.
For more information, you can read the complete article here.